Andea, Teofista M.
HRN: 00-67-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2026
CEFTRIAXONE 1G (VIAL)
01/03/2026
01/10/2026
IV
2g
Od
Cap Mr
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes